GHK-Cu peptide claims on TikTok: what the research actually supports

What did @draarianahernandez actually say?

Here's the problem: the transcript attached to this video has nothing to do with GHK-Cu, peptides, or aesthetic medicine. The words in the transcript, about books, cash checks, and buying cards, appear to be either a mistranscription, a technical error, or content from a completely different video. There is no usable quote from this creator to evaluate directly.

What we can work with is the caption, which makes specific claims: that GHK-Cu is a "potent biomodulator" capable of stimulating cellular regeneration, rejuvenating skin, and strengthening hair. Those are the claims worth examining, because they're what 42,800 viewers saw. The caption frames GHK-Cu as a star ingredient used through a platform called Vitaria, positioned as "advanced science." That framing deserves scrutiny regardless of what the audio said.

Does the science back this up?

Partially, and the nuance matters. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has a legitimate research base, but most of it is preclinical or in vitro. Calling it a proven skin rejuvenator in 2024 overstates the human evidence.

The peptide was first isolated by Loren Pickart in 1973 and has been studied for decades. In vitro studies consistently show it can stimulate collagen synthesis, modulate matrix metalloproteinases, and exhibit antioxidant activity. Pickart and Margolina (2018, Biomolecules) published a review documenting these mechanisms and GHK-Cu's role in activating genes associated with tissue repair. A 2015 study by Finkley et al. in the Journal of Wound Care found topical GHK-Cu improved wound healing markers in human subjects. For hair, animal studies and some small human trials suggest it may prolong the anagen phase, but head-to-head data against established treatments like minoxidil is thin. The honest summary: promising preclinical data, limited but real human trial evidence, and a long way from "regeneración celular" as a confirmed outcome.

What did they get wrong (or right)?

The caption gets the basic biology directionally correct. GHK-Cu does appear to influence fibroblast activity and collagen production. That part is not fabricated. Credit where it's due.

What's overstated is the confidence level. Describing GHK-Cu as a confirmed "biomodulador potente" for skin rejuvenation and hair strengthening skips over the fact that most compelling data comes from lab dishes and rodents, not randomized controlled trials in humans. A 2020 systematic review by Gorouhi and Maibach in Skin Pharmacology and Physiology noted that while copper peptides show biological plausibility, high-quality clinical evidence remains sparse. The promotional framing, tying this to a specific commercial platform called Vitaria, also means this video is functioning as marketing dressed as education. That's a meaningful distinction viewers deserve to know. The hashtag "ghkcuhn" (likely Honduras-specific) suggests a regional market angle, which raises questions about what formulation, concentration, and delivery method is actually being sold.

What should you actually know?

GHK-Cu is not snake oil, but it's also not a proven regenerative treatment. Here's what the current evidence actually supports.

Topical GHK-Cu at concentrations around 0.01 to 1 percent has shown collagen-stimulating effects in fibroblast cultures. Some small human studies support modest improvements in skin texture and fine lines when used consistently. For hair loss, the mechanism, promoting follicle survival and extending growth phase, is biologically plausible, but clinical evidence does not yet support replacing evidence-based treatments. Injectable or systemic GHK-Cu sits in a different regulatory and evidence category entirely. The FDA has not approved GHK-Cu for any indication. Compounded formulations vary significantly in quality and concentration. Anyone being offered GHK-Cu through a telehealth or aesthetic platform should ask directly: what concentration, what delivery method, and what does the provider consider a realistic outcome? "Advanced science" is not a substitute for that conversation.